These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 27997897

  • 1. Plasma Gelsolin Promotes Proliferation of Mesangial Cell in IgA Nephropathy.
    Zhang L, Kong D, Meng H, Han C, Zhu J, Qiao J, He Y, Wang T, Li X, Zhang F, Jin X.
    Cell Physiol Biochem; 2016; 40(6):1473-1486. PubMed ID: 27997897
    [Abstract] [Full Text] [Related]

  • 2. Plasma Gelsolin Induced Glomerular Fibrosis via the TGF-β1/Smads Signal Transduction Pathway in IgA Nephropathy.
    Zhang L, Han C, Ye F, He Y, Jin Y, Wang T, Wu Y, Jiang Y, Zhang F, Jin X.
    Int J Mol Sci; 2017 Feb 12; 18(2):. PubMed ID: 28208683
    [Abstract] [Full Text] [Related]

  • 3. Plasma gelsolin levels are decreased and correlate with fibrosis in IgA nephropathy.
    Han C, Zhang L, Zhu X, Tang J, Jin X.
    Exp Biol Med (Maywood); 2013 Nov 01; 238(11):1318-27. PubMed ID: 24047794
    [Abstract] [Full Text] [Related]

  • 4. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H, Zhang L, E X, Ye F, Li H, Han C, Yamakawa M, Jin X.
    Transl Res; 2014 Jan 01; 163(1):8-18. PubMed ID: 23891568
    [Abstract] [Full Text] [Related]

  • 5. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.
    Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I.
    Int Immunol; 2012 Apr 01; 24(4):219-32. PubMed ID: 22298882
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Apr 01; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 7. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, Iyoda M, Honda H, Shibata T.
    PLoS One; 2020 Apr 01; 15(4):e0232194. PubMed ID: 32324811
    [Abstract] [Full Text] [Related]

  • 8. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 9. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 05; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 10. Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.
    Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2013 Apr 05; 8(8):e73425. PubMed ID: 24023680
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC.
    Kidney Int; 2022 Feb 05; 101(2):274-287. PubMed ID: 34756952
    [Abstract] [Full Text] [Related]

  • 12. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
    Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A.
    J Immunol Res; 2020 Feb 05; 2020():4284379. PubMed ID: 32537466
    [Abstract] [Full Text] [Related]

  • 13. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Feb 05; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 14. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug 05; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 15. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar 11; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 17. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 11; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 18. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec 11; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.
    Dai Q, Liu J, Du YL, Hao X, Ying J, Tan Y, He LQ, Wang WM, Chen N.
    Acta Pharmacol Sin; 2016 Feb 11; 37(2):228-34. PubMed ID: 26775659
    [Abstract] [Full Text] [Related]

  • 20. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Feb 11; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.